Rivastigmine in frontotemporal dementia: an open-label study.

@article{Moretti2004RivastigmineIF,
  title={Rivastigmine in frontotemporal dementia: an open-label study.},
  author={Rita Moretti and Paola Della Torre and Rodolfo M. Antonello and Tatiana Cattaruzza and Giuseppe Cazzato and A. Cazzato G. Bava},
  journal={Drugs & aging},
  year={2004},
  volume={21 14},
  pages={
          931-7
        }
}
OBJECTIVE This preliminary open-label study aims to investigate the effects of rivastigmine, an inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), in 20 patients diagnosed with frontotemporal dementia (FTD). PATIENTS AND METHODS Study subjects were men and women 60-75 years of age diagnosed with probable FTD. The rivastigmine group received doses of 3-9 mg/day. The control group included matched patients receiving antipsychotics, benzodiazepines and selegiline… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 53 CITATIONS

The behavioral variant of frontotemporal dementia: An analysis of the literature and a case report.

  • International journal of law and psychiatry
  • 2016
VIEW 9 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Frontotemporal Dementias: A Review

VIEW 5 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Pharmacological treatment of frontotemporal lobar degeneration: systematic review.

  • Revista brasileira de psiquiatria
  • 2011
VIEW 4 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED

Medical management of frontotemporal dementia.

  • American journal of Alzheimer's disease and other dementias
  • 2007
VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Clinical Psychopharmacology for Neurologists

  • Springer International Publishing
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2005
2018

CITATION STATISTICS

  • 6 Highly Influenced Citations

  • Averaged 2 Citations per year over the last 3 years

  • 33% Increase in citations per year in 2018 over 2017

Similar Papers

Loading similar papers…